Renalytix plc, a company that uses artificial intelligence to diagnose and treat kidney disease, has announced that it is considering selling itself or its assets after receiving an unsolicited takeover offer from a larger competitor. The company, which is listed on both the London Stock Exchange and the Nasdaq, said that it has launched a…